HIMS
HealthcareHims & Hers Health, Inc.
$24.35+0.51 (+2.14%)
Prev Close
$23.84
Open
$24.07
High
$24.82
Low
$23.25
Volume
36.65M
Market Cap
$4.99B
P/E
47.75
Div Yield
—
Over the past 12 months, insider activity at Hims & Hers Health, Inc. (HIMS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 73 insider sales totaling $160.41M. The most recent insider transaction was by Boughton Soleil (officer: Chief Legal Officer), who sold $70.7K worth of shares on Mar 2, 2026. Hims & Hers Health, Inc. operates in the Healthcare sector, within the Medical - Equipment & Services industry, with a market cap of $4.99B.
Buys (12M)
0
$0.00
Sells (12M)
73
$160.41M
Net Activity
Net Seller
$160.41M
Active Insiders
9
last 12 mo
HIMS Price Chart
HIMS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026↗ | Boughton Soleil | officer: Chief Legal Officer | Sell | 4,651 | $15.21 | $70.7K | 440,972 |
| Feb 4, 2026↗ | Okupe Oluyemi | officer: Chief Financial Officer | Sell | 5,262 | $26.44 | $139.1K | 91,617 |
| Feb 3, 2026↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 5,262 | $26.44 | $139.1K | 0 |
| Jan 21, 2026↗ | Okupe Oluyemi | officer: Chief Financial Officer | Sell | 9,067 | $30.34 | $275.1K | 91,617 |
| Jan 20, 2026↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 9,067 | $30.34 | $275.1K | 0 |
| Jan 7, 2026↗ | Okupe Oluyemi | officer: Chief Financial Officer | Sell | 9,070 | $33.79 | $306.5K | 91,617 |
| Jan 5, 2026↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 9,070 | $33.79 | $306.5K | 0 |
| Dec 22, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 23,090 | $35.72 | $824.7K | 0 |
| Dec 17, 2025↗ | Autor Deborah M. | Chief Policy Officer | Sell | 7,054 | $36.71 | $259.0K | 0 |
| Dec 17, 2025↗ | Becklund Irene | PAO | Sell | 8,411 | $36.71 | $308.8K | 0 |
| Dec 17, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 10,021 | $36.71 | $367.9K | 0 |
| Dec 17, 2025↗ | Chi Michael | Chief Operating Officer | Sell | 13,750 | $36.71 | $504.8K | 0 |
| Dec 15, 2025↗ | Becklund Irene | PAO | Sell | 8,867 | $36.25 | $321.4K | 0 |
| Dec 15, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 22,817 | $36.25 | $827.1K | 0 |
| Dec 15, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 6,500 | $36.25 | $235.6K | 0 |
| Dec 15, 2025↗ | Chi Michael | Chief Operating Officer | Sell | 39,870 | $36.25 | $1.45M | 0 |
| Dec 15, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 90,660 | $36.25 | $3.29M | 0 |
| Dec 15, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 58,010 | $36.25 | $2.10M | 0 |
| Dec 9, 2025↗ | Perez Garcia Andrea G | Director | Sell | 2,500 | $39.17 | $97.9K | 0 |
| Nov 24, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,631 | $35.22 | $92.7K | 0 |
| Nov 17, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 23,187 | $36.81 | $853.5K | 0 |
| Nov 10, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $42.53 | $112.2K | 0 |
| Oct 27, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $50.10 | $132.1K | 0 |
| Oct 17, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,592 | $57.13 | $662.2K | 0 |
| Oct 16, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 175,661 | $62.79 | $11.03M | 0 |
| Oct 13, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $54.38 | $143.4K | 0 |
| Oct 10, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 900 | $58.25 | $52.4K | 0 |
| Oct 3, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,595 | $57.72 | $669.2K | 0 |
| Oct 1, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 250 | $56.00 | $14.0K | 0 |
| Sep 29, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $58.79 | $155.0K | 0 |
| Sep 29, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 85,000 | $60.20 | $5.12M | 0 |
| Sep 22, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 23,584 | $57.74 | $1.36M | 0 |
| Sep 17, 2025↗ | Becklund Irene | PAO | Sell | 8,410 | $50.50 | $424.7K | 0 |
| Sep 17, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $50.50 | $133.2K | 0 |
| Sep 17, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 10,021 | $50.50 | $506.1K | 0 |
| Sep 17, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 13,749 | $50.50 | $694.3K | 0 |
| Sep 17, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 65,110 | $50.57 | $3.29M | 0 |
| Sep 15, 2025↗ | Becklund Irene | PAO | Sell | 8,867 | $53.96 | $478.5K | 0 |
| Sep 15, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 22,829 | $53.96 | $1.23M | 0 |
| Sep 15, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 6,500 | $53.96 | $350.7K | 0 |
| Sep 15, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 44,022 | $54.15 | $2.38M | 0 |
| Sep 15, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 266,333 | $53.61 | $14.28M | 0 |
| Sep 15, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 203,021 | $54.95 | $11.16M | 0 |
| Aug 26, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,581 | $43.69 | $506.0K | 0 |
| Aug 25, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,571 | $44.53 | $114.5K | 0 |
| Aug 18, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 175,661 | $45.06 | $7.91M | 0 |
| Aug 13, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,581 | $48.05 | $556.4K | 0 |
| Aug 11, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,572 | $51.64 | $132.8K | 0 |
| Aug 7, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 660,000 | $50.58 | $33.38M | 0 |
| Aug 6, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 60,000 | $53.58 | $3.21M | 0 |
Showing 1–50 of 306
1 / 7
...
HIMS Insider Buying Activity
The following table shows recent insider purchases of Hims & Hers Health, Inc. (HIMS) stock reported via SEC Form 4 filings.
No insider buying activity found for HIMS in the last 12 months.
HIMS Insider Selling Activity
The following table shows recent insider sales of Hims & Hers Health, Inc. (HIMS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026↗ | Boughton Soleil | officer: Chief Legal Officer | Sell | 4,651 | $15.21 | $70.7K | 440,972 |
| Feb 4, 2026↗ | Okupe Oluyemi | officer: Chief Financial Officer | Sell | 5,262 | $26.44 | $139.1K | 91,617 |
| Feb 3, 2026↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 5,262 | $26.44 | $139.1K | 0 |
| Jan 21, 2026↗ | Okupe Oluyemi | officer: Chief Financial Officer | Sell | 9,067 | $30.34 | $275.1K | 91,617 |
| Jan 20, 2026↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 9,067 | $30.34 | $275.1K | 0 |
| Jan 7, 2026↗ | Okupe Oluyemi | officer: Chief Financial Officer | Sell | 9,070 | $33.79 | $306.5K | 91,617 |
| Jan 5, 2026↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 9,070 | $33.79 | $306.5K | 0 |
| Dec 22, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 23,090 | $35.72 | $824.7K | 0 |
| Dec 17, 2025↗ | Autor Deborah M. | Chief Policy Officer | Sell | 7,054 | $36.71 | $259.0K | 0 |
| Dec 17, 2025↗ | Becklund Irene | PAO | Sell | 8,411 | $36.71 | $308.8K | 0 |
| Dec 17, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 10,021 | $36.71 | $367.9K | 0 |
| Dec 17, 2025↗ | Chi Michael | Chief Operating Officer | Sell | 13,750 | $36.71 | $504.8K | 0 |
| Dec 15, 2025↗ | Becklund Irene | PAO | Sell | 8,867 | $36.25 | $321.4K | 0 |
| Dec 15, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 22,817 | $36.25 | $827.1K | 0 |
| Dec 15, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 6,500 | $36.25 | $235.6K | 0 |
| Dec 15, 2025↗ | Chi Michael | Chief Operating Officer | Sell | 39,870 | $36.25 | $1.45M | 0 |
| Dec 15, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 90,660 | $36.25 | $3.29M | 0 |
| Dec 15, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 58,010 | $36.25 | $2.10M | 0 |
| Dec 9, 2025↗ | Perez Garcia Andrea G | Director | Sell | 2,500 | $39.17 | $97.9K | 0 |
| Nov 24, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,631 | $35.22 | $92.7K | 0 |
| Nov 17, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 23,187 | $36.81 | $853.5K | 0 |
| Nov 10, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $42.53 | $112.2K | 0 |
| Oct 27, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $50.10 | $132.1K | 0 |
| Oct 17, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,592 | $57.13 | $662.2K | 0 |
| Oct 16, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 175,661 | $62.79 | $11.03M | 0 |
| Oct 13, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $54.38 | $143.4K | 0 |
| Oct 10, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 900 | $58.25 | $52.4K | 0 |
| Oct 3, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,595 | $57.72 | $669.2K | 0 |
| Oct 1, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 250 | $56.00 | $14.0K | 0 |
| Sep 29, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $58.79 | $155.0K | 0 |
| Sep 29, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 85,000 | $60.20 | $5.12M | 0 |
| Sep 22, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 23,584 | $57.74 | $1.36M | 0 |
| Sep 17, 2025↗ | Becklund Irene | PAO | Sell | 8,410 | $50.50 | $424.7K | 0 |
| Sep 17, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,637 | $50.50 | $133.2K | 0 |
| Sep 17, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 10,021 | $50.50 | $506.1K | 0 |
| Sep 17, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 13,749 | $50.50 | $694.3K | 0 |
| Sep 17, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 65,110 | $50.57 | $3.29M | 0 |
| Sep 15, 2025↗ | Becklund Irene | PAO | Sell | 8,867 | $53.96 | $478.5K | 0 |
| Sep 15, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 22,829 | $53.96 | $1.23M | 0 |
| Sep 15, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 6,500 | $53.96 | $350.7K | 0 |
| Sep 15, 2025↗ | Chi Michael | Chief Commercial Officer | Sell | 44,022 | $54.15 | $2.38M | 0 |
| Sep 15, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 266,333 | $53.61 | $14.28M | 0 |
| Sep 15, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 203,021 | $54.95 | $11.16M | 0 |
| Aug 26, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,581 | $43.69 | $506.0K | 0 |
| Aug 25, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,571 | $44.53 | $114.5K | 0 |
| Aug 18, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 175,661 | $45.06 | $7.91M | 0 |
| Aug 13, 2025↗ | Okupe Oluyemi | Chief Financial Officer | Sell | 11,581 | $48.05 | $556.4K | 0 |
| Aug 11, 2025↗ | Boughton Soleil | Chief Legal Officer | Sell | 2,572 | $51.64 | $132.8K | 0 |
| Aug 7, 2025↗ | Dudum Andrew | Chief Executive Officer | Sell | 660,000 | $50.58 | $33.38M | 0 |
| Aug 6, 2025↗ | Carroll Patrick Harrison | Chief Medical Officer | Sell | 60,000 | $53.58 | $3.21M | 0 |
HIMS Insiders
Similar Stocks to HIMS
LLY
Eli Lilly and Company
$984.11+0.70%
$921.90B
JNJ
Johnson & Johnson
$241.86-0.07%
$583.29B
ABBV
AbbVie Inc.
$220.81-2.02%
$398.49B
MRK
Merck & Co., Inc.
$115.92+0.00%
$286.57B
UNH
UnitedHealth Group Incorporated
$281.12+1.48%
$251.47B
AMGN
Amgen Inc.
$366.74-0.29%
$198.26B
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
GILD
Gilead Sciences, Inc.
$144.25-0.66%
$180.27B